AASANDHA SCHEME
Master Medicine and Consumable list as at 14th May 2026
test
| Code | mfda_code | Generic | Product name | Strength | Volume | Preparation | Master Price (MVR) |
|---|---|---|---|---|---|---|---|
| M2335 | P2575 | Telmisartan + Hydrochlorothiazide | Telmed H | 40 mg + 12.5 mg | Tablet | 3.97 | |
| M2764 | P3527 | Telmisartan + Hydrochlorothiazide | T-Sartan-H | 40 mg + 12.5 mg | Tablet | 2.94 | |
| M3784 | P5002 | Telmisartan + Hydrochlorothiazide + Amlodipine | Telvas-3D | 40 mg + 12.5 mg + 5 mg | Tablet (Bilayered) | 5.12 | |
| TM0722 | P4368 | Temozolomide | Temozolomide | 20 mg | Capsule | 178.5 | |
| TM0723 | P4369 | Temozolomide | Temozolomide | 100 mg | Capsule | 791.52 | |
| TM0724 | P4370 | Temozolomide | Temozolomide | 250 mg | Capsule | 2080.8 | |
| M3859 | P6843 | Teneligliptin | Glytrin | 20 mg | Tablet | 3.44 | |
| TM0679 | P3973 | Teneligliptin | Teneligliptin | 20 mg | Tablet | 3.83 | |
| M3926 | P6896 | Teneligliptin + Metformin | Glytrin - Met 500 | 20 mg + 500 mg | Tablet (ER) | 4.17 | |
| M3927 | P6897 | Teneligliptin + Metformin | Glytrin - Met 1000 | 20 mg + 1000 mg | Tablet (ER) | 4.53 | |
| TM0680 | P3971 | Teneligliptin + Metformin | Teneligliptin + Metformin | 20 mg + 1000 mg | Tablet (ER) | 4.59 | |
| TM0681 | P3972 | Teneligliptin + Metformin | Teneligliptin + Metformin | 20 mg + 500 mg | Tablet (ER) | 4.59 | |
| M2339 | P0003 | Terazosin | Hytrin | 5 mg | Tablet | 8.16 | |
| M2340 | P0004 | Terazosin | Hytrin | 1 mg | Tablet | 5.1 | |
| M2341 | P0005 | Terazosin | Hytrin | 2 mg | Tablet | 6.12 | |
| M2342 | P1273 | Terbinafine | Lamisil | 125 mg | Tablet | 5.1 | |
| M2343 | P1274 | Terbinafine | Lamisil | 250 mg | Tablet | 10.2 | |
| M2344 | P1275 | Terbinafine | Lamisil | 0.01 | Cream | 45.9 | |
| M2345 | P1888 | Terbinafine | Sebifen | 0.01 | 10 gm | Cream | 61.2 |
| M3532 | P4541 | Terbinafine | Terbin | 0.01 | 15 gm | Cream | 63.05 |